Pakeeza Arzoo Shaiq

Dr. Pakeeza Arzoo Shaiq

University Institute of Biochemistry and Biotechnology, Pir Mehr Ali Shah Arid Agriculture University, Rawalpindi, Punjab, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2013 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
PSPakeeza Arzoo Shaiq
Pakeeza Arzoo Shaiq
PSP.E. Stuart
P.E. Stuart
ALAyse Latif
Ayse Latif
CSC. Schmotzer
C. Schmotzer
AKA.H. Kazmi
A.H. Kazmi
RNR.P. Nair
R.P. Nair
Background Genetic predisposition to psoriasis, an inflammatory skin disease affecting 0·2–4% of the world population, is well established. Thus far, 41 psoriasis susceptibility loci reach genome‐wide significance (P ≤ 5 × 10−8). Identification of genetic susceptibility loci in diverse populations will help understand the underlying biology of psoriasis susceptibility. Objectives The primary objective of this study was to examine psoriasis susceptibility associations previously reported in Chinese and caucasian populations in a Pakistani cohort. Methods Blood samples and phenotype data were collected from psoriasis cases and controls in Islamabad, Pakistan. DNA was isolated and genotypes of selected susceptibility markers were determined. The data were analysed using χ2 tests or logistic regression for psoriasis association. Results HLA‐Cw6 showed the strongest association [odds ratio (OR) 2·43, P = 2·3 × 10−12]. HLA‐Cw1 showed marginally significant association (OR 1·66, P = 0·049), suggesting that the HLA‐Cw1‐B46 risk haplotype may be present in the Pakistani population. Three other loci (IL4/IL13, NOS2, TRAF3IP2) showed nominally significant association (P < 0·05). Conclusions HLA‐Cw6 is strongly associated with psoriasis susceptibility in the Pakistani population, as has been found in every other population studied. In addition, HLA‐Cw1 showed marginal association, reflecting the relative geographical proximity and thus likely genetic relatedness to other populations in which the HLA‐Cw1‐B46 haplotype is known to be associated. A larger cohort and a denser marker set will be required for further analysis of psoriasis associations in the South Asian population.

23 December 2022 in Genes
Verified
Journal Article
Open access
PDF file
MAMaria Asif
Maria Asif
MAMaryam Anayat
Maryam Anayat
FTFaiza Tariq
Faiza Tariq
TNTanzeela Noureen
Tanzeela Noureen
GDGhulam Naseer Ud Din
Ghulam Naseer Ud Din
UAUzma Abdullah
Uzma Abdullah
Intellectual disability (ID) is a condition of significant limitation of cognitive functioning and adaptive behavior, with 50% of etiology attributed to genetic predisposition. We recruited two consanguineous Pakistani families manifesting severe ID and developmental delay. The probands were subjected to whole exome sequencing (WES) and variants were further prioritized based on population frequency, predicted pathogenicity and functional relevance. The WES data analysis identified homozygous pathogenic variants in genes MBOAT7 and TRAPPC9. The pathogenicity of the variants was supported by co-segregation analysis and in silico tool. The findings of this study expand mutation spectrum and provide additional evidence to the role of MBOAT7 and TRAPPC9 in causation of ID.

28 November 2022 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
MMMariam Ahmed Mujtaba
Mariam Ahmed Mujtaba
MRMatthew Richardson
Matthew Richardson
HSHira Shahzad
Hira Shahzad
MJMuhammad Ishaq Javed
Muhammad Ishaq Javed
GRGhazala Kaukab Raja
Ghazala Kaukab Raja
SSSadia Saeed
Sadia Saeed
Objective. TB recurrence is the second episode of TB after initial treatment bringing about an additional 7% load in TB burden intensified by 17.7% of multidrug-resistant recurrent cases. It is necessary to curb recurrence so that attempts to deal with active disease can be made more effective. This study aimed to characterize sociodemographic and clinical factors associated with recurrent TB in a high-burden setting. Methodology. A retrospective case-control study was carried out at two hospitals in Rawalpindi, Pakistan. TB patients and controls were included in the study. Sociodemographic and clinical data were collected by questionnaire from all subjects. Multivariate regression analysis was performed to determine factors associated with TB and TB recurrence respectively. Results. In our study cohort, factors significantly associated with TB were low BMI (OR: 0.961 (CI 0.954–0.968), ), female gender (OR: 2.065 (CI 1.922–2.219), ), being single/unmarried (OR: 1.214 (CI 1.109–1.328), ), middle-income status (OR: 1.935 (CI 1.616–2.323), ), smoking (OR: 1.567 (CI 1.435–1.710), ), and diabetes mellitus (OR: 1.142 (CI 1.017–1.278), ). TB recurrence constituted 11.2% of patients presenting to the hospital. Compared with the first episode of TB, cases with recurrence were more likely to be older (OR: 1.011 (CI 1.004–1.017), ), have disease awareness (OR: 1.906 (CI 1.486–2.437), ), smear positive (OR: 2.384 (CI 1.650–3.536), ), and be drug-resistant (OR: 5.615 (CI 4.265–7.386), ). Conclusion. In the present study cohort, low BMI, female gender, being single, middle-income status, being unemployed, smoking, and being diabetic came out to be the sociodemographic and clinical risk factors for TB. Further exploring the TB cases increasing age, drug resistance and smear positivity stood out to be the major sociodemographic and clinical factors of TB recurrence despite high disease awareness.

27 November 2022 in Genes
Verified
Journal Article
Open access
PDF file
Muhammad Mobeen ZafarMuhammad Mobeen Zafar
Muhammad Mobeen Zafar
MSMuhammad Saqlain
Muhammad Saqlain
.R.Asad Mehmood Raja
.Asad Mehmood Raja
PSPakeeza Arzoo Shaiq
Pakeeza Arzoo Shaiq
MAMuhammad Javaid Asad
Muhammad Javaid Asad
GRGhazala Kaukab Raja
Ghazala Kaukab Raja
The world population is genetically predisposed to metabolic syndrome (MetS) and its components, also known as cardiometabolic risk phenotypes, which can cause severe health complications including coronary heart disease (CHD). Genetic variants in the 9p21 locus have been associated with CHD in a number of populations including Pakistan. However, the role of the 9p21 locus in MetS and cardiometabolic risk phenotypes (such as obesity, hypertension, hyperglycemia, and dyslipidemia) in populations with CHD or no established CHD has not been explored. Therefore, the present study was designed to explore the association of the minor/risk allele (C) of 9p21 locus SNP rs1333049 with MetS or its risk phenotypes regardless of an established CHD, in Pakistani subjects. Genotyping of rs1333049 (G/C) was performed on subjects under a case-control study design; healthy controls and cases, MetS with CHD (MetS-CHD+) and MetS with no CHD (MetS-CHD−), respectively. Genotype and allele frequencies were calculated in all study groups. Anthropometric and clinical variables (Means ± SD) were compared among study groups (i.e., controls, MetS + CHD and MetS-CHD) and minor/risk C allele carriers (GC + CC) vs. non-carriers (Normal GG genotype). Associations of the risk allele of rs1333049 SNP with disease and individual metabolic risk components were explored using adjusted multivariate logistic regression models (OR at 95% CI) with a threshold p-value of ≤0.05. Our results have shown that the minor allele frequency (MAF) was significantly high in the MAF cases (combined = 0.63, MetS-CHD+ = 0.57 and MetS-CHD− = 0.57) compared with controls (MAF = 0.39). The rs1333049 SNP significantly increased the risk of MetS, irrespective of CHD (MetS-CHD+ OR = 2.36, p < 0.05 and MetS-CHD− OR = 4.04, p < 0.05), and cardiometabolic risk phenotypes; general obesity, central obesity, hypertension, and dyslipidemia (OR = 1.56–3.25, p < 0.05) except hyperglycemia, which lacked any significant association (OR = 0.19, p = 0.29) in the present study group. The 9p21 genetic locus/rs1333049 SNP is strongly associated with, and can be a genetic predictor of, MetS and cardiometabolic risks, irrespective of cardiovascular diseases in the Pakistani population.

26 February 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
UHUmme Habiba
Umme Habiba
AMAafia malik
Aafia malik
GRGhazala Kaukab Raja
Ghazala Kaukab Raja
MMMuhammad Raza Memon
Muhammad Raza Memon
ANAsad Tameezud Din Nizami
Asad Tameezud Din Nizami
PSPakeeza Arzoo Shaiq
Pakeeza Arzoo Shaiq
Schizophrenia patients demonstrate variations in response to different therapies that are currently being used for the treatment of disorders, such as augmentation therapy (ECT or mood stabilizer) and combination therapy (with antipsychotics). These therapies are also used to treat schizophrenia patients in Pakistan; however, patients show poor overall response. Therefore, this study was conducted to investigate the association between the patients’ response to treatment and the use of antipsychotic agents, with variability in overall response, within different groups of patients. Methods: We conducted a retrospective study that included schizophrenia subjects (N = 200) belonging to different age groups, ethnicities, and regions from different outpatient and inpatient departments in psychiatric institutes located in different cities of Pakistan. These patients were assessed for their response to treatment therapies and categorized into four groups (non-responders (N-R), slow response (S-R), patients with relapse, and completely recovered patients (C-R)) according to their responses. Results: The final analysis included 200 subjects, of which 73.5% were males. Mean age was 34 ± 10 years. Percentage of N-R was 5%, S-R was 42%, patients with relapse were 24%, and C-R was 1.5%. The generalized linear regression model shows a significant association between medication response and age (p = 0.0231), age of onset (p = 0.0086), gender (p = 0.005), and marital status (p = 0.00169). Variability within the medication responses was a result of the treatment regime followed. Antipsychotic agents were significantly associated with the treatment response (p = 0.00258, F = 4.981) of the patients. Significant variation was also observed in the treatment response (p = 0.00128) of the patients that were given augmentation therapy as well as combination therapy. Conclusion: The data suggests proper monitoring of patients’ behavior in response to treatment therapies to implement tailored interventions. Despite several genetic studies supporting the heritability of schizophrenia, an insignificant association between characteristic features and family history might have been due to the limited sample size, suggesting collaborative work with massive sample sizes.

22 May 2023 in Genes
Verified
Journal Article
Open access
PDF file
RIRAFAQAT ISHAQ
RAFAQAT ISHAQ
MIMuhammad Ilyas
Muhammad Ilyas
UHUmme Habiba
Umme Habiba
MAMuhammad Noor ul Amin
Muhammad Noor ul Amin
SSSadia Saeed
Sadia Saeed
ZAZubair Ahmed
Zubair Ahmed
Vitiligo is an autoimmune complex pigmentation disease characterized by non-pigmented patches on the surface of the skin that affect approximately 0.5–2% population worldwide. The exact etiology is still unknown; however, vitiligo is hypothesized to be a multifactorial and genetically heterogeneous condition. Therefore, the current study is designed to investigate the anthropometric presentation and genetic spectrum of vitiligo in fifteen consanguineous Pakistani families. The clinical evaluation of participating individuals revealed varying degrees of disease severity, with 23 years as the average age of disease onset. The majority of the affected individuals had non-segmental vitiligo (NSV). Whole exome sequencing analysis revealed clustering of rare variants of known vitiligo-associated genes. For instance, in the affected individuals of family VF-12, we identified three novel rare variants of PTPN22 (c.1108C>A), NRROS (c.197C>T) and HERC2 (c.10969G>A) genes. All three variants replaced evolutionarily conserved amino acid residues in encoded proteins, which are predicted to impact the ionic interactions in the secondary structure. Although various in silico algorithms predicted low effect sizes for these variants individually, the clustering of them in affected individuals increases the polygenic burden of risk alleles. To our knowledge, this is the first study that highlights the complex etiology of vitiligo and genetic heterogeneity in multiplex consanguineous Pakistani families.